Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

ClinicalTrials.gov ID: NCT04030143

Public ClinicalTrials.gov record NCT04030143. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 12:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b, Open-label, Multiple-dose, Randomized, Parallel-arm, Safety, Tolerability, and Pharmacokinetic Trial of Aripiprazole Intramuscular Depot Administered in the Gluteal Muscle in Adult Subjects With Schizophrenia or Bipolar I Disorder

Study identification

NCT ID
NCT04030143
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
266 participants

Conditions and interventions

Interventions

  • Aripiprazole Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2019
Primary completion
Jul 7, 2020
Completion
Jul 7, 2020
Last update posted
Nov 17, 2023

2019 – 2020

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Woodland International Research Group Little Rock Arkansas 72211
Woodland International Research Group Rogers Arkansas 72758
CITrials - Bellflower Bellflower California 90706
Collaborative Neuroscience Network Garden Grove California 92845
California Clinical Trials Medical Group Glendale California 91206
Synergy Research Centers Lemon Grove California 91945
NRC Research Institute Orange California 92868
California Neuropsychopharmacology Clinical Research Institute San Diego San Diego California 92102
Collaborative Neuroscience Network - South Bay Torrance California 90502
Research Centers of America Hollywood Florida 33024
Segal Institute For Clinical Research - West Broward Outpatient Clinic Miami Lakes Florida 33016
Atlanta Center for Medical Research - Atlanta Atlanta Georgia 30331
CBH Health Gaithersburg Maryland 20877
St. Louis Clinical Trials St Louis Missouri 63141
Altea Research Institute - Las Vegas Las Vegas Nevada 89102
Hassman Research Institute Marlton New Jersey 08009
Midwest Clinical Research Center Dayton Ohio 45417
Carolina Clinical Trials Charleston South Carolina 29407
Community Clinical Research Austin Texas 78754

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04030143, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2023 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04030143 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →